Jinyu Bio-Technology

Jinyu Bio-Technology is a company listed under the stock ticker 600201 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Jinyu Bio-Technology

• Jing Zhang, Chief Executive Officer and Vice Chairman of the Board
• Ming Geng, Independent Director
• Riming Gao, Director

Create your alert
to follow the executive moves at Jinyu Bio-Technology.

Jinyu Bio-Technology has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Jinyu Bio-Technology

Social media about Jinyu Bio-Technology

• Jinyu Bio-Technology on Wikipedia, Google News & Yahoo Finance
• Jinyu Bio-Technology on LinkedIn, Twitter & YouTube

Call Jinyu Bio-Technology at +86 471...

View the org chart

Register to receive your alert

Report an error